Genetic and vascular disorder treatment company Clinuvel Pharmaceuticals (ASX:CUV) released a new strategic update on Monday.
The firm plans to expand its research capabilities for skin cancer treatments and damage remediation. The establishment of a new manufacturing division is on the company’s strategic agenda to advance new treatment formulas.
The strategic update has done little to boost investor appetite, as shares in Clinuvel Pharmaceuticals are trading 2.42 per cent lower at $29.39 .
Copyright 2021 – Finance News Network
28 Aug 2020 - Diversified payment company, FlexiGroup (ASX:FXL) has raised $79 million after completing the institutional component of its 1 for 3.2 pro rata accelerated non-renounceable entitlement offer.
23 Sep 2020 - Nufarm (ASX:NUF) today reported a statutory net loss after tax for financial year 2020 of $456 million and underlying earnings before interest, tax, depreciation and amortisation from continuing operations of $236 million.
07 Jan 2022 - A snapshot of the stocks on the move featuring Priceline owner (ASX:API), Magellan Financial Group (ASX:MFG), and Pinnacle Investment (ASX:PNI).
08 Jan 2020 - Global logistics solutions group, WiseTech Global (ASX:WTC) has acquired SISA Studio Informatica,a leading customs and freight forwarding solutions provider in Switzerland.
03 Jul 2020 - Worley (ASX:WOR) has been awarded a services contract from BASF. The contract is for engineering, procurement and construction management services needed to assist the company’s European battery material investment project in Finland.
09 Jul 2020 - Treasury Wine Estates (ASX:TWE) has posted a 21% decline in FY20 EBITS, with regional declines of approximately 14 per cent in Asia, 37 per cent in the Americas, 16 per cent in ANZ and 18 per cent in Europe, the Middle East and Africa.
24 Jan 2020 - Oceania Healthcare (ASX:OCA) released their half yearly accounts showing net profit after tax was 17.6 per cent up from the first half of 2019 for the six months to 30 November 2019.
20 Nov 2020 - Following the Banking Royal Commission, Commonwealth Bank of Australia (ASX:CBA) introduced a Remedial Action Plan, outlining the steps its board and senior leaders would take to respond to the Inquiry’s 35 recommendations.
